Frontlight ResearchEarly access
CompletedPhase 2
Intranasal Insulin for Posttraumatic Stress Disorder
Key facts
- Who runs it
- VA Connecticut Healthcare System
- Where
- West Haven, United StatesSee the site
- Trial code
- Status
- Completed
- Phase
- Phase 2
- People taking part
- 10 people enrolled
- Started
- 31 Oct 2024
- Ended
- 28 May 2026
- Type of study
- Interventional, 2 groups
- Treatments tested
- Intranasal insulin
- Placebo
- Record updated
- 13 July 2026
Who can take part
- Age
- 21 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Male or female, 21-65 years old
- Current PTSD
- Able to provide written informed consent
Who cannot take part
- Changes in doses of psychotropic medications in the past 4 weeks
- Initiation of individual therapy or counseling in the past 4 weeks
- Unstable medical condition, clinically determined by a physician
- Diabetes requiring insulin or oral hypoglycemic agents
- Current psychotic disorder, bipolar disorder, cognitive disorder in the past 12 months
- Current substance use disorders (except alcohol, tobacco, or cannabis) in the past 3 months
- History of claustrophobia
- Presence of cardiac pacemaker or other electronic device or ferromagnetic metal foreign bodies in vulnerable positions as assessed by a standard pre-MRI safety screening questionnaire
- Moderate-severe traumatic brain injury
- Imminent suicidal or homicidal risk
- Contraindication to Insulin
Where in United States
- VA Connecticut Healthcare SystemWest Haven, United States
About the trial
What the trial wants to find out
To evaluate if intranasal insulin is effective in reducing PTSD symptoms.
The 2 groups in the trial
- Intranasal insulinTreatment being tested
Subjects in this arm will receive 40 IU of intranasal insulin twice a day (80 IU per day).
- PlaceboTreatment being tested
Subjects in this arm will receive placebo.
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Intranasal Insulin for Treating Posttraumatic Stress Disorder
- Record updated
- 13 July 2026